 CHARLOTTESVILLE, Va., Dec. 20, 2021 GLOBE NEWSWIRE -- Diffusion Pharmaceuticals Inc . NASDAQ: DFFN Diffusion or the Company, a biopharmaceutical company developing novel therapies that enhance the bodys ability to deliver oxygen to areas where it is needed most, announced today that the Company will present at H.C. Wainwright BioConnect and participate in Biotech Showcase and BIO Partnering at JPM. All three events are scheduled alongside the J.P. Morgan 40th Annual Healthcare Conference 2022. 